Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

9.455 -0.320 (-3.27%)
Streaming Delayed Price Updated: 3:28 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
From DBV Technologies S.A.
Via GlobeNewswire
DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids
DBV Technologies secures FDA guidance for Accelerated Approval of its Viaskin Peanut patch, advancing treatment for toddlers with peanut allergies through pivotal trials. 
Via Benzinga
Wall Street Poised To Open Lower A Day After Nasdaq's Record Close Above 20,000: Expert Flags 'Deterioration Under The Surface' As 117 S&P 500 Stocks Hit New Monthly Lows
U.S. stock futures declined on Thursday in premarket hours after hitting fresh highs on Wednesday. S&P 500, Dow, Nasdaq 100 & R2K were down. 
Via Benzinga
Topics Stocks
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
From DBV Technologies S.A.
Via GlobeNewswire
Information regarding the total number of voting rights and  total number of shares of the Company as of November 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Reports Third Quarter 2024 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
Tesla To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Via AB Newswire
Topics Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
DBV Technologies progresses with regulatory efforts for its Viaskin Peanut patch in the U.S. and Europe, while financial concerns loom as the company seeks additional funding to continue its... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
From DBV Technologies S.A.
Via GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From DBV Technologies S.A.
Via GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
From DBV Technologies S.A.
Via GlobeNewswire
DBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q2 2024
DBVT stock results show that DBV Technologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.